A detailed history of Endurance Wealth Management, Inc. transactions in Outlook Therapeutics, Inc. stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 20,000 shares of OTLK stock, worth $100,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 10,000 100.0%
Holding current value
$100,600
Previous $11,000 218.18%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$1.02 - $1.89 $10,200 - $18,900
10,000 Added 100.0%
20,000 $35,000
Q1 2023

May 02, 2023

BUY
$1.0 - $1.35 $10,000 - $13,500
10,000 New
10,000 $11,000
Q3 2021

Oct 28, 2021

BUY
$2.12 - $2.76 $31,800 - $41,400
15,000 New
15,000 $33,000

Others Institutions Holding OTLK

About Outlook Therapeutics, Inc.


  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.14B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Endurance Wealth Management, Inc. Portfolio

Follow Endurance Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endurance Wealth Management, Inc. with notifications on news.